1-4 of 4
Leo Gordon, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase I Multi-Dose Escalation Study of the Anti-CD19 Maytansinoid Immunoconjugate SAR3419 Administered by Intravenous (IV) Infusion Every 3 Weeks to Patients with Relapsed/ Refractory B-Cell Non-Hodgkin's Lymphoma (NHL).

Free
Anas Younes, MD, Leo Gordon, MD, Stella Kim, MD, Jorge Romaguera, MD, Amanda R Copeland, MS, Silvana de Castro Farial, MD, Larry Kwak, MD, PHD, Luis Fayad, MD, Frederick Hagemeister, MD, Michelle Fanale, M.D., John Lambert, PhD, Teresa Bagulho, MD, Rodica Morariu-Zamfir, MD
Journal: Blood
Blood (2009) 114 (22): 585.
https://doi.org/10.1182/blood.V114.22.585.585
Published: 2009
Journal Articles

Motexafin Gadolinium (MGd) Has Clinical Activity in Relapsed/Refractory Low Grade Lymphomas (LG) and Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL).

Free
Brad S. Kahl, MD, Ranjana Advani, MD, Neil Kay, MD, Izidore S. Lossos, MD, Andrew Evens, DO, Leo Gordon, MD, Richard A. Miller, MD, See-Chun Phan, MD
Journal: Blood
Blood (2005) 106 (11): 4758.
https://doi.org/10.1182/blood.V106.11.4758.4758
Published: 2005
Journal Articles

Comparison of Out-of-Pocket Costs for Patients (pts) with Hodgkin’s Disease (HD), Indolent Non-Hodgkin’s Lymphoma (INHL) and Aggressive Non-Hodgkin’s Lymphoma (ANHL).

Free
Kathryn McCaffrey, BA, Matthew Fisher, Lucie Kutikova, PhD, Lee Bowman, PhD, Andrew Evens, DO, Leo Gordon, MD, Heather Auto, Charles Bennett, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 2241.
https://doi.org/10.1182/blood.V106.11.2241.2241
Published: 2005
Journal Articles

Rituximab, Bevacizumab (Avastin) and CHOP (RA-CHOP) for Patients with Diffuse Large B-Cell Lymphoma (DLBCL).

Free
Kristen N. Ganjoo, MD, Leo Gordon, MD, Michael J. Robertson, MD, Sandra J. Horning, MD
Journal: Blood
Blood (2004) 104 (11): 1384.
https://doi.org/10.1182/blood.V104.11.1384.1384
Published: 2004